Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-03-19
1996-02-13
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 221, 536 231, 536 241, 536 2431, 536 2433, 536 254, 435 6, 435 691, 436501, A01N 4334, C07H 1512, A61K 31395
Patent
active
054911338
ABSTRACT:
The use of oligodeoxynucleotides modified at the 3'-terminal internucleotide link as therapeutic agents by a method of hybridizing the modified oligonucleotide to a complementary sequence within a targeted mRNA and cleaving the mRNA within the RNA-DNA helix by the enzyme RNaseH to block the expression of the corresponding gene.
REFERENCES:
Dagle et al. (1991) Antisense Research and Development, vol. 1, pp. 11-20.
Minshull et al. (1986) Nucleic Acids Res., vol. 14, No. 16, pp. 6433-6451.
Eckestein (1983) Angewandte Chemie, vol. 22, No. 6, pp. 423-439.
Marcus-Sekura, C. J. et al., 1987, Nucleic Acids Res. 15:5749-5763.
Dagle John M.
Eder Paul S.
Walder Joseph A.
Walder Roxanne Y.
Low Christopher S. F.
University of Iowa Research Foundation
LandOfFree
Methods for blocking the expression of specifically targeted gen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for blocking the expression of specifically targeted gen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for blocking the expression of specifically targeted gen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240625